An organic state trace element solution for rheumatoid arthritis treatment by modulating macrophage phenotypic from M1 to M2 - 05/01/24

Abstract |
Trace elements (TEs) are essential for the treatment of rheumatoid arthritis (RA). This study aimed to prepare a TEs solution enriched with various organic states to evaluate its preventive, therapeutic effects, and mechanism of action in RA and to provide a treatment method for RA treatment. The TEs in natural ore were extracted and added to 0.5% (W/V) L-alanyl-L-glutamine (LG) to obtain a TEs solution (LG-WLYS), which was examined for its concentration and quality. The antioxidant properties and effects of LG-WLYS on cell behavior were evaluated at the cellular level. The preventive and therapeutic effects and mechanism of action of LG-WLYS in rats with RA were explored. The LG-WLYS solution was clear, free from visible foreign matter, and had a pH of 5.33 and an osmolality of 305.67 mOsmol/kg. LG-WLYS inhibited cell migration and angiogenesis. LG-WLYS solution induced macrophages to change from M1-type to M2-type, increased the content of antioxidant enzymes (glutathione, superoxide dismutase, and IL-10), decreased the levels of nitric oxide, malondialdehyde, TNF-α, IL-1β, IL-6, COX-2, and iNOs, scavenging reactive oxygen species from the lesion site, inhibiting the apoptosis of chondrocytes, regulating inflammatory microenvironment, and decreasing inflammation response to exert the therapeutic effect for RA. In conclusion, LG-WLYS has outstanding therapeutic and preventive effects against RA and has enormous potential for further development.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | An organic state trace element solution (LG-WLYS) was successfully prepared. |
• | The LG-WLYS exerts an anti-inflammatory effect by scavenging reactive oxygen species. |
• | The LG-WLYS treats rheumatoid arthritis by modulating macrophage phenotype. |
• | The LG-WLYS can prevent the development of inflammatory diseases. |
Keywords : Rheumatoid arthritis, Trace elements, Prophylactic, Macrophage phenotypic
Plan
Vol 170
Article 116025- janvier 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?